Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients (Q46729975)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients |
scientific article |
Statements
1 reference
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients (English)
1 reference
Giovanni Martinelli
1 reference
Michele Baccarani
1 reference
Emanuela Ottaviani
1 reference
Eliana Zuffa
1 reference
Monica Bocchia
1 reference
Alfonso Zaccaria
1 reference
Paolo Avanzini
1 reference
Nicoletta Testoni
1 reference
Mauro Fiacchini
1 reference
Michele Malagola
1 reference
Michela Rondoni
1 reference
Renato Fanin
1 reference
Donatella Raspadori
1 reference
Daniela Damiani
1 reference
Patrizio Mazza
1 reference
Domenico Russo
1 reference
Antonio de Vivo
1 reference
Pier P Piccaluga
1 reference
Anna Candoni
1 reference
Angela Michielutti
1 reference
Maurizio Castelli
1 reference
Giancarla Pricolo
1 reference
Francesco Lauria
1 reference
Alessandro Bonini
1 reference
Luigi Gugliotta
1 reference
Giuseppe Visani
1 reference
1 October 2005
1 reference
131
1 reference
2
1 reference
172-179
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference